Fibrosis Progression in Nonalcoholic Fatty Liver vs Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis of Paired-Biopsy Studies
Top Cited Papers
Open Access
- 24 April 2014
- journal article
- research article
- Published by Elsevier BV in Clinical Gastroenterology and Hepatology
- Vol. 13 (4), 643-654.e9
- https://doi.org/10.1016/j.cgh.2014.04.014
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Genetic Covariance Between γ-Glutamyl Transpeptidase and Fatty Liver Risk Factors: Role of β2-Adrenergic Receptor Genetic Variation in TwinsGastroenterology, 2010
- Nonalcoholic Fatty Liver Disease Increases Risk of Death Among Patients With Diabetes: A Community-Based Cohort StudyThe American Journal of Gastroenterology, 2010
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic SteatohepatitisThe New England Journal of Medicine, 2010
- Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitisJournal of Hepatology, 2009
- The effect of metformin and standard therapy versus standard therapy alone in nondiabetic patients with insulin resistance and nonalcoholic steatohepatitis (NASH): a pilot trialTherapeutic Advances in Gastroenterology, 2009
- Long-Term Follow-Up of Patients With Nonalcoholic Fatty LiverClinical Gastroenterology and Hepatology, 2009
- Placebo in Nonalcoholic Steatohepatitis: Insight Into Natural History and Implications for Future Clinical TrialsClinical Gastroenterology and Hepatology, 2008
- The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLDJournal of Hepatology, 2007
- Measuring inconsistency in meta-analysesBMJ, 2003
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986